Swapping colonoscopies for swallowing a pill packed with bacteria that can read the condition of our gut could revolutionize ...

Mirikizumab (Omvoh) is effective in inducing a clinical response in adults with moderate-to-severe ulcerative colitis and ...

Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...

Adults with IBD who achieved delayed remission by week 30 after starting advanced therapy had similar 1-year clinical and endoscopic outcomes as early remitters.

Week held in Berlin, Germany, an informative session explored emerging approaches for the management of ulcerative colitis (UC), ranging from surgical interventions to updated treatment guidelines and ...

Proactive care and early treatment help prevent serious IBD complications and improve patients’ quality of life.

Ulcerative colitis is a chronic, immune-mediated disorder of the colon, which is characterised by a relapsing–remitting course. Owing to the growing understanding of the immunopathogenesis of this ...